Evidence map›Paper›PMID 29995922›Full record

Observational studyPloS one2018

P-wave duration is a predictor for long-term mortality in post-CABG patients.

Sheila Tatsumi Kimura-Medorima, Ana Paula Beppler Lazaro Lino, Marcel P C Almeida, Marcio J O Figueiredo, Lindemberg da Mota Silveira-Filho, Pedro Paulo Martins de Oliveira, Otavio Rizzi Coelho, José Roberto Matos Souza, Wilson Nadruz, Orlando Petrucci and 1 more

Abstract readObservational Study
In one paragraph

Observational study in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Effect of pulmonary embolism location on electrocardiological parameters.Revista da Associacao Medica Brasileira (1992) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sheila Tatsumi Kimura-MedorimaCardiology Division, State University of Campinas (Unicamp), Campinas, São Paulo, Brazil.
Ana Paula Beppler Lazaro LinoCardiology Division, State University of Campinas (Unicamp), Campinas, São Paulo, Brazil.
Marcel P C AlmeidaCardiology Division, State University of Campinas (Unicamp), Campinas, São Paulo, Brazil.
Marcio J O FigueiredoCardiology Division, State University of Campinas (Unicamp), Campinas, São Paulo, Brazil.ORCID 0000-0002-3477-4667
Lindemberg da Mota Silveira-FilhoSurgery Department, State University of Campinas (Unicamp), Campinas, São Paulo, Brazil.ORCID 0000-0002-4585-2747
Pedro Paulo Martins de OliveiraSurgery Department, State University of Campinas (Unicamp), Campinas, São Paulo, Brazil.
Otavio Rizzi CoelhoCardiology Division, State University of Campinas (Unicamp), Campinas, São Paulo, Brazil.
José Roberto Matos SouzaCardiology Division, State University of Campinas (Unicamp), Campinas, São Paulo, Brazil.
Wilson NadruzCardiology Division, State University of Campinas (Unicamp), Campinas, São Paulo, Brazil.
Orlando PetrucciSurgery Department, State University of Campinas (Unicamp), Campinas, São Paulo, Brazil.
Andrei C SpositoCardiology Division, State University of Campinas (Unicamp), Campinas, São Paulo, Brazil.ORCID 0000-0001-7127-2052

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Risk stratification in secondary prevention has emerged as an unmet clinical need in order to mitigate the Number-Needed-to-Treat and make expensive therapies both clinically relevant and cost-effective. P wave indices reflect atrial conduction, which is a sensitive marker for inflammatory, metabolic, and pressure overload myocardial cell remodeling; the three stimuli are traditional mechanisms for adverse clinical evolution. Accordingly, we sought to investigate the predictive role of P-wave indices to estimate residual risk in patients with chronic coronary artery disease (CAD). The cohort included 520 post-Coronary Artery Bypass Grafting patients with a median age of 60 years who were followed for a median period of 1025 days. The primary endpoint was long-term all-cause death. Cubic spline model demonstrated a linear association between P-wave duration and incidence rate of long-term all-cause death (p = 0.023). P-wave >110ms was a marker for an average of 425 days shorter survival as compared with P-wave under 80ms (Logrank p = 0.020). The Cox stepwise regression models retained P-wave duration as independent marker (HR:1.37; 95%CI:1.05-1.79,p = 0.023). In conclusion, the present study suggests that P-wave measurement may constitute a simple, inexpensive and accessible prognostic tool to be added in the bedside risk estimation in CAD patients.

Indexed as

Heart RateAgedCoronary Artery BypassCoronary Artery DiseaseElectrocardiographyFemaleHumansMaleMiddle AgedPostoperative Complications

Identifiers

PMID29995922
PMCPMC6040706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.